Computing delocalized chiral carbon system of molecular transfer and processing loop feed forward/back of biooranic meta states would require sofisticated premises of space -energy natural physics of nano modules -
Did you know you could use AI tools to accelerate drug discovery? Join Standigm on 26 September to explore how its innovative use of Synthia’s AI tools is accelerating the development of therapeutic solutions. Register: https://rsc.li/3ZovIwb
Please join me at the #AIPM2024 - Generative AI in Medical Research & Drug Development: Hype or Reality? https://lnkd.in/gPHytRGZ #ai #clinicalresearch #genai
📢 Calling all drug discovery professionals! Now's the time to secure your place on Eurofins Discovery's webinar on 26th June! ✅ Understand the use of Artificial Intelligence methodologies in the development and application of ADME-based models ✅ Understand the importance of high-quality data and chemical space coverage in AI approaches to ADME model development ✅ Learn appropriate use of AI-based ADME models from the application of SAFIRE in real drug discovery projects ✅ See how application of SAFIRE as part of the screening process can increase the likelihood of success from the beginning of drug discovery projects. Register here >> https://bit.ly/43Y6hSz Unable to make it? Don't worry - register your details and we'll send you the recording. #AI #DrugDiscovery #Screening
it is always interesting to hear from industry leaders on human-led AI on drug discovery in a recently discovered bloomberg article from january 2024 (see comment). “Will we in five years see full-blown drug discovery based on AI? I think that’s the million-dollar sort of question. (...) But while AI can speed up the work, ultimately putting a drug in the hand of the patient has got to be a human decision based." - Anders Romare Chief Digital Officer at Novo Nordisk #ai #drugdiscovery #humanledai #novonordisk #innovation #healthcare
Director IT Delivery and Product Management | EB1A Recipient & Advisory Coach | AI/ML | FHIR | SaaS | Self Directed Care
The drug discovery process has traditionally been a time-consuming, costly, and intricate endeavor. From the initial identification of potential drug candidates to the rigorous clinical trials required for regulatory approval, it can take over a decade and billions of dollars to bring a new drug to market. However, the advent of artificial intelligence (AI) is revolutionizing this landscape, offering unprecedented opportunities to accelerate and enhance various stages of drug discovery. This article explores how AI is transforming the drug discovery process and what the future holds for this synergistic field. https://lnkd.in/eDacnHwz #AI #DrugDiscovery
AI is making waves in drug discovery, but it’s important to recognize the current limitations and challenges. While AI is a powerful tool, it won’t be replacing lab experiments or human expertise anytime soon. Instead, it will enhance how we approach complex problems in drug discovery. At Kvantify, we see the potential of combining AI with physics-based models to overcome obstacles like data sparsity, lack of diversity, and inconsistencies in datasets. Our models provide a rigorous way to validate and complement AI-driven insights, reducing the risks of generalization errors and improving decision-making in drug development. We're proud to offer solutions that help advance drug discovery, especially with our product Koffee that addresses the challenges of predicting unbinding kinetics and binding affinity. Read more in Mikael Hvidtfeldt Christensen blogpost here: https://lnkd.in/dWG8ftSX
Have you watched the recent #AI in Forecasting #webinar with J+D Forecasting yet? Catch up and listen to the panel discuss some of the practical applications of AI in #pharma, specifically within forecasting: https://ow.ly/4aaJ50SXCVk
Real world AI application: drug discovery - make predictions for data-scarce clinical outcomes by leveraging abundant discovery data. https://lnkd.in/gMyMw62k
At last week's #TechBioUK the BioIndustry Association (BIA) launched its 'TechBio: UK leads innovation frontier' report in collaboration with Citeline. The report delves into the latest advancements driven by AI and data-driven approaches, which are revolutionising drug discovery, diagnostics and personalised medicine. Access it here - https://ow.ly/YJOy50TNsoF #AI #Data #DrugDiscovery
AI In Drug Discovery & Development Artificial Intelligence (AI) is revolutionizing drug discovery and development! 🌟 By leveraging machine learning and big data, AI accelerates the identification of potential drug candidates, predicts drug efficacy, and streamlines clinical trials. This innovative approach reduces costs, shortens development timelines, and increases the success rate of bringing new treatments to market. The future of medicine is here, driven by AI! 💊🤖 #AIDrugDiscovery #PharmaInnovation #FutureOfMedicine #HealthcareTech https://lnkd.in/gQqpBhCh
#AI is already transforming initiatives across research, patient communications, drug discovery, and genomics, as well as patient care, diagnosis, and treatment. In this webinar, we cover how AI can assist with various #languageservices, including multilingual content generation, #translation, and more, to help build bridges to a healthier world. https://brnw.ch/21wHoT0
